REAL-WORLD EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOAC) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF): A RETROSPECTIVE COHORT STUDY IN SINGAPORE

被引：0
|
作者：
Foo, W. [1 ]
Hui, T. [2 ]
Ong, S. K. B. [1 ]
Ng, K. H. [1 ]
机构：
[1] Agcy Care Effectiveness, Minist Hlth, Singapore, Singapore
[2] Agcy Care Effectiveness, Minist Hlth, Singapore 01, Singapore
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P73
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [41] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
    Renda, Giulia
    Ricci, Fabrizio
    Giugliano, Robert P.
    De Caterina, Raffaele
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1363 - 1371
  • [42] The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
    Grymonprez, Maxim
    Petrovic, Mirko
    De Backer, Tine L.
    Steurbaut, Stephane
    Lahousse, Lies
    [J]. THROMBOSIS AND HAEMOSTASIS, 2024, 124 (02) : 135 - 148
  • [43] Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Moon, Inki
    Lee, So-Ryoung
    Choi, Eue-Keun
    Lee, Euijae
    Jung, Jin-Hyung
    Han, Kyung-Do
    Cha, Myung-Jin
    Oh, Seil
    Lip, Gregory Y. H.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [44] CLINICAL AND ECONOMIC IMPLICATIONS OF USING NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS FOR NON-VALVULAR ATRIAL FIBRILLATION USING AVAILABLE EVIDENCE FROM REAL-WORLD EXPERIENCE
    Lorenzoni, V
    Pirri, S.
    Turchetti, G.
    [J]. VALUE IN HEALTH, 2019, 22 : S554 - S554
  • [45] Eligibility criteria for non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in the real world
    Augusto, J. B.
    Santos, M. Borges
    Roque, D.
    Silva, M.
    Castro, J.
    Sala, J.
    Faustino, A.
    Branco, M.
    Morais, J.
    Morais, C.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 236 - 236
  • [46] Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol
    Esteve Pastor, M. A.
    Rivera-Caravaca, J. M.
    Roldan, V.
    Orenes-Pinero, E.
    Romiti, G. F.
    Romanazzi, I.
    Bai, Y.
    Carmo, J.
    Proietti, M.
    Marin, F.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 873 - 873
  • [47] Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort
    Giustozzi, M.
    Vedovati, M. C.
    Cianella, F.
    Verdecchia, P.
    Verso, M.
    Conti, S.
    Filippucci, E.
    Marchesini, E.
    Agnelli, G.
    Becattini, C.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1085 - 1085
  • [48] Real-life use of non-vitamin k antagonist oral anticoagulants in comparison with vitamin k antagonists for non-valvular atrial fibrillation: data from a prospective cohort
    Giustozzi, M.
    Vedovati, M. C.
    Cianella, F.
    Verdecchia, P.
    Verso, M.
    Conti, S.
    Filippucci, E.
    Marchesini, E.
    Agnelli, G.
    Becattini, C.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 396 - 397
  • [49] Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation
    Kwon, Chang Hee
    Kim, Minsu
    Kim, Jun
    Nam, Gi-Byoung
    Choi, Kee-Joon
    Kim, You-Ho
    [J]. JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (07) : 566 - 572
  • [50] Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
    Xue, Zhengbiao
    Zhou, Yue
    Wu, Chaoyu
    Lin, Jie
    Liu, Xin
    Zhu, Wengen
    [J]. HEART FAILURE REVIEWS, 2020, 25 (06) : 957 - 964
12345